Digital ulcers in systemic sclerosis: their epidemiology, clinical characteristics, and associated clinical and economic burden

[1]  J. D. de Vries-Bouwstra,et al.  Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. , 2018, Clinical and experimental rheumatology.

[2]  Simon Gibbs,et al.  2015 ESC/ERS Guidelines for the Diagnosis and Treatment of Pulmonary Hypertension. , 2016, Revista espanola de cardiologia.

[3]  A. Torbicki,et al.  Wytyczne ESC/ERS dotyczaçe rozpoznawania i leczenia nadciśnienia płucnego w 2015 roku , 2015 .

[4]  Laura C. Cappelli,et al.  Management of Raynaud Phenomenon and Digital Ulcers in Scleroderma. , 2015, Rheumatic diseases clinics of North America.

[5]  U. Müller-Ladner,et al.  Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database , 2015, Annals of the rheumatic diseases.

[6]  Y. Asano,et al.  Vasculopathy in scleroderma , 2015, Seminars in Immunopathology.

[7]  U. Müller-Ladner,et al.  An observational cohort study of patients with newly diagnosed digital ulcer disease secondary to systemic sclerosis registered in the EUSTAR database. , 2015, Clinical and experimental rheumatology.

[8]  D. M. van der Heijde,et al.  Digital ulcers predict a worse disease course in patients with systemic sclerosis , 2015, Annals of the rheumatic diseases.

[9]  M. Mayes,et al.  An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative , 2013 .

[10]  C. Denton,et al.  Functional impairment of systemic scleroderma patients with digital ulcerations: results from the DUO Registry. , 2013, Clinical and experimental rheumatology.

[11]  M. Baron,et al.  Associations with digital ulcers in a large cohort of systemic sclerosis: Results from the Canadian Scleroderma Research Group registry , 2011, Arthritis care & research.

[12]  P. Nash,et al.  The manifestations of vasculopathy in systemic sclerosis and its evidence‐based therapy , 2009, International journal of rheumatic diseases.

[13]  J. Gerss,et al.  Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors , 2009, The British journal of dermatology.

[14]  J. Sibilia,et al.  Incidence and prevalence of systemic sclerosis: a systematic literature review. , 2008, Seminars in arthritis and rheumatism.

[15]  E. Hachulla,et al.  Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study. , 2007, The Journal of rheumatology.

[16]  C. Denton,et al.  Clinical burden of digital vasculopathy in limited and diffuse cutaneous systemic sclerosis , 2007, Annals of the rheumatic diseases.

[17]  U. Müller-Ladner,et al.  Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database , 2007, Annals of the rheumatic diseases.

[18]  C. Schentag,et al.  Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. , 2006, The Journal of rheumatology.

[19]  S. Bombardieri,et al.  Systemic Sclerosis: Demographic, Clinical, and Serologic Features and Survival in 1,012 Italian Patients , 2002, Medicine.

[20]  A. Herrick,et al.  Digital ulcers in systemic sclerosis , 2017, Rheumatology.

[21]  F. Peruzzi,et al.  Digital ulcers as a sentinel sign for early internal organ involvement in very early systemic sclerosis. , 2015, Rheumatology.

[22]  Simon Gibbs,et al.  [2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension]. , 2015, Kardiologia polska.

[23]  L. Punzi,et al.  The social costs of digital ulcer management in sclerodema patients: an observational Italian pilot study. , 2010, Joint, bone, spine : revue du rhumatisme.